FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

427032006: Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3693888012 Retapamulin 10 mg/g cutaneous ointment en Synonym Active Entire term case insensitive SNOMED CT core module
3693889016 Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
47954901000001113 Retapamulin 1% ointment en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Is a Product containing retapamulin false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has active ingredient Retapamulin false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form Conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Is a Topical antibacterial false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Is a Product manufactured as cutaneous dose form false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has concentration strength denominator unit gram true Inferred relationship Existential restriction modifier 1
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has precise active ingredient Retapamulin true Inferred relationship Existential restriction modifier 1
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has concentration strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has concentration strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has concentration strength numerator value 10 false Inferred relationship Existential restriction modifier 1
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has basis of strength substance Retapamulin true Inferred relationship Existential restriction modifier 1
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Is a Product containing only retapamulin in cutaneous dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Plays role Antibacterial therapeutic role true Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has active ingredient Retapamulin false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form Conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Is a Retapamulin true Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route ointment.cutaneous ontology form and route true Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Topical route false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Cutaneous true Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form Cutaneous dose form true Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form Conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form Conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has specific active ingredient Retapamulin true Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Altargo 1% ointment (GlaxoSmithKline) Is a True Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Retapamulin 1% ointment 5 gram Is pack of False Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Retapamulin 1% ointment 5 gram Has VMP True Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start